Immunotherapy: The development of immunotherapy in urothelial bladder cancer

Nat Rev Clin Oncol. 2015 Apr;12(4):193-4. doi: 10.1038/nrclinonc.2015.51. Epub 2015 Mar 17.

Author

Tom Powles¹

Affiliation

¹ Barts Cancer Institute, Barts Health and the Royal Free NHS Trust, Queen Mary University of London, London EC1A 7BE, UK.

PMID: 25781573
DOI: 10.1038/nrclinonc.2015.51

No abstract available

Publication types

News

MeSH terms

Biomarkers, Tumor / metabolism
Carcinoma, Transitional Cell / diagnosis
Carcinoma, Transitional Cell / therapy*
Humans
Immunotherapy / methods
Immunotherapy / trends*
Prognosis
Urinary Bladder Neoplasms / diagnosis
Urinary Bladder Neoplasms / therapy*

Substances

Biomarkers, Tumor